Title : Randomized Phase II Study of Docetaxel plus Personalized Peptide Vaccination versus Docetaxel plus Placebo for Patients with Previously Treated Advanced Wild Type EGFR Non-Small-Cell Lung Cancer.

Pub. Date : 2016

PMID : 27274999






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Randomized Phase II Study of Docetaxel plus Personalized Peptide Vaccination versus Docetaxel plus Placebo for Patients with Previously Treated Advanced Wild Type EGFR Non-Small-Cell Lung Cancer. Docetaxel epidermal growth factor receptor Homo sapiens